How fathers' use of e-cigarettes affects blood clotting in their children
The Mechanistic Impact of Paternal Electronic Nicotine Delivery Systems Exposure on Thrombogenesis
This study is looking at how dads who use e-cigarettes might affect their children's health, specifically focusing on blood clotting and any related issues, so we can better understand the risks for families.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-11192952 on NIH RePORTER |
What this research studies
This research investigates the effects of fathers' exposure to electronic nicotine delivery systems (ENDS), such as e-cigarettes, on blood clotting and related health issues in their children. The study will explore how paternal ENDS exposure influences platelet function and counts, as well as the overall coagulation system. It will also examine the potential inflammatory responses and the genetic changes in both fathers and their offspring that may result from this exposure. By understanding these mechanisms, the research aims to shed light on the health risks associated with ENDS use in fathers and its implications for their children's health.
Who could benefit from this research
Good fit: Ideal candidates for this research include children whose fathers use electronic nicotine delivery systems.
Not a fit: Patients who do not have fathers that use e-cigarettes or similar products may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and prevention of thrombotic diseases in children exposed to ENDS through their fathers.
How similar studies have performed: While the effects of paternal smoking on health have been studied, the specific impact of ENDS on thrombogenesis is a novel area of investigation.
Where this research is happening
College Station, United States
- Texas A&m University Health Science Ctr — College Station, United States (Active)
Researchers
- Principal investigator: Khasawneh, Fadi T — Texas A&m University Health Science Ctr
- Study coordinator: Khasawneh, Fadi T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.